Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rotmensz

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|November 1, 1985
Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ V Hamerlynck, A P Maskens, C Mangioni, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative GroupJ P Neijt, M E van der Burg, J P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2012
HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?M Iorfida, S Dellapasqua, V Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesM Colleoni, N Rotmensz, G Peruzzotti, et al.
Ecancermedicalscience|January 26, 2012
Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002E Botteri, S Iodice, P Maisonneuve, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ B Vermorken, J P Armand, A J Lacave, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 19, 2015
Oncological results of oncoplastic breast-conserving surgery: Long term follow-up of a large series at a single institution: A matched-cohort analysisF De Lorenzi, G Hubner, N Rotmensz, et al.
British Journal of Cancer|October 12, 2000
Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimetersP Autier, J F Doré, A C Reis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
When can a second conservative approach be considered for ipsilateral breast tumour recurrence?O Gentilini, E Botteri, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2010
Cancer-testis antigen expression in triple-negative breast cancerG Curigliano, G Viale, M Ghioni, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|November 1, 1985
Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ V Hamerlynck, A P Maskens, C Mangioni, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative GroupJ P Neijt, M E van der Burg, J P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2012
HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?M Iorfida, S Dellapasqua, V Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesM Colleoni, N Rotmensz, G Peruzzotti, et al.
Ecancermedicalscience|January 26, 2012
Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002E Botteri, S Iodice, P Maisonneuve, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ B Vermorken, J P Armand, A J Lacave, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 19, 2015
Oncological results of oncoplastic breast-conserving surgery: Long term follow-up of a large series at a single institution: A matched-cohort analysisF De Lorenzi, G Hubner, N Rotmensz, et al.
British Journal of Cancer|October 12, 2000
Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimetersP Autier, J F Doré, A C Reis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
When can a second conservative approach be considered for ipsilateral breast tumour recurrence?O Gentilini, E Botteri, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2010
Cancer-testis antigen expression in triple-negative breast cancerG Curigliano, G Viale, M Ghioni, et al.
Pageof 10